IRONWOOD PHARMACEUTICALS INC(NASDAQ:IRWD) stock Analyst Ratings

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 73% to IRWD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.22. This target is 459.8% above the current price.

IRWD was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about IRWD.

In the last month the buy percentage fell by 9 points. So the trust of analysts is decreasing.

IRWD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price

Low

Median

Mean

High

0.93

0.71

1.02

5.22

14.70

-24.17%

9.41%

459.80%

1,476.75%

Up and Down Grades

Date	Firm	Action	Rating
2025-04-15	Wells Fargo	Downgrade	Overweight -> Equal-Weight
2025-04-15	Jefferies	Downgrade	Buy -> Hold
2025-04-14	Leerink Partners	Maintains	Market Perform -> Market Perform
2025-01-30	JMP Securities	Maintains	Market Outperform -> Market Outperform
2025-01-22	Craig-Hallum	Maintains	Buy -> Buy
2024-09-09	Leerink Partners	Initiate	Market Perform
2024-08-09	Wells Fargo	Maintains	Overweight -> Overweight
2024-08-09	Craig-Hallum	Maintains	Buy -> Buy
2024-05-10	Craig-Hallum	Maintains	Buy -> Buy
2024-03-01	Wells Fargo	Maintains	Overweight -> Overweight
2024-02-16	Piper Sandler	Maintains	Overweight -> Overweight
2024-01-17	Craig-Hallum	Initiate	Buy
2023-12-14	Wells Fargo	Initiate	Overweight
2023-09-28	JMP Securities	Initiate	Market Outperform
2023-05-23	Piper Sandler	Maintains	Overweight -> Overweight
2022-08-16	Wells Fargo	Maintains	Equal-Weight
2022-04-22	Piper Sandler	Initiate	Overweight
2021-10-12	Morgan Stanley	Maintains	Equal-Weight
2021-07-16	Morgan Stanley	Maintains	Equal-Weight
2021-02-22	Morgan Stanley	Maintains	Equal-Weight
2021-02-19	Morgan Stanley	Maintains	Equal-Weight

IRONWOOD PHARMACEUTICALS INC (IRWD) Stock Analyst Ratings